pyrazolanthrone has been researched along with Degenerative Diseases, Central Nervous System in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (71.43) | 24.3611 |
2020's | 2 (28.57) | 2.80 |
Authors | Studies |
---|---|
Reddy, PA; Siddiqui, MA | 1 |
Ahmad, R; Ahmad, S; Ikram, M; Khan, A; Khan, MS; Kim, MO; Rehman, IUR | 1 |
Cao, H; Chen, Z; Chi, S; Guo, S; Hu, Q; Sun, T; Tao, H; Yang, J; Zhang, L; Zhu, H | 1 |
Geng, C; Wei, J; Wu, C | 1 |
Fan, Z; Li, P; Mei, C; Wang, X; Zhang, M; Zhao, C | 1 |
Gao, R; Jiang, L; Liu, J; Liu, Y; Qian, W; Wang, J; Xiao, H; Zhou, J; Zhu, J | 1 |
Davies, C; Tournier, C | 1 |
1 review(s) available for pyrazolanthrone and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Exploring the function of the JNK (c-Jun N-terminal kinase) signalling pathway in physiological and pathological processes to design novel therapeutic strategies.
Topics: Animals; Anthracenes; Apoptosis; Brain; Enzyme Activation; Humans; Isoenzymes; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Neoplasms; Neurodegenerative Diseases | 2012 |
6 other study(ies) available for pyrazolanthrone and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Small molecule JNK (c-Jun N-terminal kinase) inhibitors.
Topics: Allosteric Regulation; Animals; Cardiovascular Diseases; Crystallography, X-Ray; Humans; Inflammation; Isoenzymes; JNK Mitogen-Activated Protein Kinases; Metabolic Diseases; Neurodegenerative Diseases; Protein Conformation; Protein Kinase Inhibitors; Signal Transduction | 2010 |
Inhibition of JNK Alleviates Chronic Hypoperfusion-Related Ischemia Induces Oxidative Stress and Brain Degeneration via Nrf2/HO-1 and NF-
Topics: Aging; Animals; Anthracenes; Apoptosis; Brain Ischemia; Heme Oxygenase-1; Hippocampus; JNK Mitogen-Activated Protein Kinases; Male; Memory Disorders; Mice, Inbred C57BL; Models, Biological; Neurodegenerative Diseases; Neurons; NF-E2-Related Factor 2; NF-kappa B; Oxidative Stress; Perfusion; Phosphorylation; Signal Transduction; Synapses; Up-Regulation | 2020 |
Small molecular compounds efficiently convert human fibroblasts directly into neurons.
Topics: Amides; Anthracenes; Cell Differentiation; Cells, Cultured; Cellular Reprogramming; Cellular Reprogramming Techniques; Colforsin; Culture Media, Conditioned; Fibroblasts; Foreskin; Humans; Indoles; Male; Maleimides; Nerve Tissue Proteins; Neurodegenerative Diseases; Neurons; Pyrazoles; Pyridines; Pyrimidines; Transcription Factors | 2020 |
Mammalian STE20-like Kinase 1 Knockdown Attenuates TNFα-Mediated Neurodegenerative Disease by Repressing the JNK Pathway and Mitochondrial Stress.
Topics: Animals; Anthracenes; Apoptosis; Cell Line, Tumor; Cytochromes c; Dose-Response Relationship, Drug; Gene Knockdown Techniques; Inflammation; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Mitochondria; Neurodegenerative Diseases; Oxidative Stress; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Reactive Oxygen Species; Tumor Necrosis Factor-alpha | 2019 |
MAPK Pathway Inhibitors Attenuated Hydrogen Peroxide Induced Damage in Neural Cells.
Topics: Animals; Anthracenes; Butadienes; Cell Survival; Enzyme Inhibitors; Humans; Hydrogen Peroxide; Imidazoles; Mice; Mitogen-Activated Protein Kinase Kinases; Neurodegenerative Diseases; Neurons; Nitriles; Oxidative Stress; PC12 Cells; Primary Cell Culture; Pyridines; Rats; Reactive Oxygen Species | 2019 |
MAPK and NF-κB pathways are involved in bisphenol A-induced TNF-α and IL-6 production in BV2 microglial cells.
Topics: Animals; Anthracenes; Anti-Inflammatory Agents; Benzhydryl Compounds; Cell Line; Endocrine Disruptors; Enzyme Activation; Estradiol; Estrogen Receptor Antagonists; Estrogen Receptor Modulators; Estrogens; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Fulvestrant; Inflammation; Interleukin-6; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; Mice; Microglia; Neurodegenerative Diseases; NF-kappa B; Phenols; Tumor Necrosis Factor-alpha | 2015 |